Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2005 Mar 21;11(11):1700-4.
doi: 10.3748/wjg.v11.i11.1700.

Correlation of CD95 and soluble CD95 expression with acute rejection status of liver transplantation

Affiliations

Correlation of CD95 and soluble CD95 expression with acute rejection status of liver transplantation

Yu-Liang Wang et al. World J Gastroenterol. .

Abstract

Aim: To analyze the expression levels of soluble form of CD95, CD95 ligand (sCD95 and sCD95L, respectively) in plasma and CD95 expression on CD3+ cells in liver-transplanted recipients with acute rejection (AR).

Methods: Peripheral blood mononuclear cells (PBMCs) were isolated from 30 clinically liver transplanted recipients. CD95 expression on CD3+ cells was quantitatively measured by two-color fluorescence activated cell sorter (FACS) analysis. Lymphocyte surface phenotypes of CD4, CD8, CD16 and CD56 were determined by flow cytometry. Plasma levels of sCD95 and sCD95L were detected by Enzyme Linked-Immuno-Sorbent Assay (ELISA). The results were compared with that from normal healthy volunteers (n = 15 individuals).

Results: FACS analysis showed that CD95 expression on CD3+ T cells was significantly increased in liver transplanted recipients with AR compared to that in stable recipients without rejection and infection or healthy individuals who did not undergo transplantation (18,676.93+/-11,588.34/molecule, 6,848.20+/-1 712.96/molecule, 6,418.01+/-2,001.95/molecule, respectively, P<0.01). Whereas no significant difference was seen between liver-transplanted stable recipients and healthy individuals. Furthermore, no significant differences were detected between each group with CD4/CD8 ratio or the percentage of CD16+56+ cells. Plasma levels of sCD95 were significantly higher in transplanted recipients with AR compared to that in stable recipients or healthy individuals (391.88+/-196.00, 201.37+/-30.30, 148.83+/-58.25 pg/mL, respectively, P<0.01). In contrast, the plasma levels of sCD95L in liver- transplanted recipients were not significantly different from that in healthy individuals.

Conclusion: The present results indicate that the increased CD95 expression on CD3+ cells and the increased levels of sCD95 in plasma may modify the immunological situation of the recipients after transplantation or represent the ongoing graft rejection.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Quantitative measurement of cell surface expression of CD95 expression on CD3+ lymphocytes PBMCs were labeled with QuantiBRITE beads suspension (T3), CD95-FITC (T2) or isotype control IgG1-FITC (T1) and CD3-PE as described in materials and methods. A: Histogram showed the expression of CD95 on CD3+ cells. Solid histogram is isotype control. Bold line: CD95; B: Histogram showed the fluorescence intensity of the mouse immunoglobulins G in T3; C: The standard curve was made by plot the MFI calibration values obtained from Figure 1B on the X-axis and their corresponding number of mAb molecules on the Y-axis.

References

    1. Gupta RK, Jain M, Sharma RK. Serum & amp; urinary interleukin-2 levels as predictors in acute renal allograft rejection. Indian J Med Res. 2004;119:24–27. - PubMed
    1. Wang YL, Tang ZQ, Gao W, Jiang Y, Zhang XH, Peng L. Influence of Th1, Th2, and Th3 cytokines during the early phase after liver transplantation. Transplant Proc. 2003;35:3024–3025. - PubMed
    1. Bathgate AJ, Lee P, Hayes PC, Simpson KJ. Pretransplantation tumor necrosis factor-alpha production predicts acute rejection after liver transplantation. Liver Transpl. 2000;6:721–727. - PubMed
    1. Drannik GN, Lunova AG, Baran YY, Poroshina TV, Kalinina NA. Cytokine producing function of type II T-helpers in transplanted kidney patients. Transplant Proc. 2001;33:2352–2354. - PubMed
    1. Radvanyi LG, Mills GB, Miller RG. Religation of the T cell receptor after primary activation of mature T cells inhibits proliferation and induces apoptotic cell death. J Immunol. 1993;150:5704–5715. - PubMed